Caudal fourth ventricular administration of the AMPK activator 5-aminoimidazole-4-carboxamide-riboside regulates glucose and counterregulatory hormone profiles, dorsal vagal complex metabolosensory neuron function, and hypothalamic fos expression

Journal of Neuroscience Research

Volumn 91, Issue 9, 2013, Pages 1226-1238

  Ibrahim, Baher A ^a   Tamrakar, Pratistha ^a   Gujar, Amit D ^a   Cherian, Ajeesh Koshy ^a   Briski, Karen P ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

A2 noradrenergic neurons; AICAR; Arcuate hypothalamic nucleus; Corticosterone; Fos immunoreactivity; Glucagon; GLUT 3; GLUT 4; MCT 2; Ovariectomy; Paraventricular hypothalamic nucleus; Subcutaneous estradiol capsule

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; GLUCOSE TRANSPORTER 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MONOCARBOXYLATE TRANSPORTER 2; PROTEIN FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; BRAIN FOURTH VENTRICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONAL REGULATION; HORMONE RELEASE; HYPOTHALAMUS; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHOMBENCEPHALON; UPREGULATION; WESTERN BLOTTING;

A2 NORADRENERGIC NEURONS; AICAR; ARCUATE HYPOTHALAMIC NUCLEUS; CORTICOSTERONE; FOS IMMUNOREACTIVITY; GLUCAGON; GLUT-3; GLUT-4; MCT-2; OVARIECTOMY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; SUBCUTANEOUS ESTRADIOL CAPSULE;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AORTIC BODIES; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FOURTH VENTRICLE; HYPOTHALAMUS; LASER CAPTURE MICRODISSECTION; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS V-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADENOSINE A2; RIBONUCLEOSIDES; SENSORY RECEPTOR CELLS; TIME FACTORS;

EID: 84880507591     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23230     Document Type: Article

References (57)

1. Alquier T, Kawashima J, Tsuji Y, Kahn BB. 2007. Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia. Endocrinology 148:1367-1375.
2. Balfour RH, Hansen AMK, Trapp S. 2006. Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstem. J Physiol 570:469-484.
3. Blouet C, Schwartz GJ. 2010. Hypothalamic nutrient sensing in the control of energy homeostasis. Behav Brain Res 209:1-12.
4. Bonen A. 2000. Lactate transporters (MCT proteins) in heart and skeletal muscles. Med Sci Sports Exerc 32:778-789.
5. Briski KP, Nedungadi TP. 2009. Adaptation of feeding and counter-regulatory hormone responses to intermediate insulin-induced hypoglycemia in the ovariectomised female rat: effects of oestradiol. J Neuroendocrinol 21:578-585.
6. Briski KP, Sylvester PW. 1998. Effects of the glucose antimetabolite, 2-deoxy-D-glucose (2-DG), on the LH surge and Fos expression by preoptic GnRH neurons in ovariectomized, steroid-primed rats. J Neuroendocrinol 10:769-776.
7. Briski KP, Sylvester PW. 1999. Site-specific induction of Fos-immunoreactivity in preoptic and hypothalamic NADPH-positive neurons during glucoprivation. Neuroendocrinology 69:181-190.
8. Briski KP, Marshall ES, Sylvester PW. 2001. Effects of estradiol on glucoprivic transactivation of catecholaminergic neurons in the female rat caudal brainstem. Neuroendocrinology 73:369-377.
9. Briski KP, Koshy Cherian A, Genabai NK, Vavaiya KV. 2009. In situ coexpression of glucose and monocarboxylate transporter mRNAs in metabolic-sensitive dorsal vagal complex catecholaminergic neurons: transcriptional reactivity to insulin-induced hypoglycemia (IIH) and caudal hindbrain glucose or lactate repletion during IIH. Neuroscience 164:1152-1160.
10. Bryant DN, Dorsa DM. 2010. Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity. Neuroscience 170:1261-1269.
11. Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC, Woods SC, Mangiaracina M, Geary N. 2007. Estradiol-dependent decrease in orexigenic potency of ghrelin in female rats. Diabetes 56:1051-1058.
12. Elzer JG, Muhammad S, Wintermantel TM, Regnier-Vigouroux A, Ludwig J, Schütz G, Schwaninger M. 2010. Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol. J Cereb Blood Flow Metab 30:935-942.
13. Estacio AMC, Yamada S, Tsukamura H, Hirunagi K, Maeda KI. 1996. Effect of fasting and immobilization stress on estrogen receptor immunoreactivity in the brain in ovariectomized female rats. Brain Res 717:55-61.
14. Foryst-Ludwig A, Kintscher U. 2010. Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 122:74-81.
15. Gingerich S, Kim GL, Chalmers JA, Koletar MM, Wang X, Wang Y, Belsham DD. 2010. Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models. Neuroscience 170:54-66.
16. Goodman RL. 1978. A quantitative analysis of the physiological role of estradiol and progesterone in the control of tonic and surge secretion of luteinizing hormone in the rat. Endocrinology 102:142-150.
17. Han SM, Namkoong C, Jang PG, Park IS, Hong SW, Katakami H, Chun S, Kim SW, Park JY, Lee KU, Kim MS. 2005. Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats. Diabetologia 48:2170-2178.
18. Hardie DG. 2003. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144:5179-5183.
19. Hayes MR, Skibicka KP, Bence KK, Grill HJ. 2009. Dorsal hindbrain 5′-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance. Endocrinology 150:2175-2182.
20. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. 2001. Effects of ischemia on gene expression. J Surg Res 99:222-227.
21. Kahn BB, Alquier T, Carling D, Hardie DG. 2005. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1:15-25.
22. Kale AY, Paranjape SA, Briski KP. 2006. Intracerebroventricular administration of the nonsteroidal glucocorticoid receptor antagonist, CP4-72555, prevents exacerbation of hypoglycemia during repeated insulin administration. Neuroscience 140:555-565.
23. Koshy Cherian A, Briski KP. 2011. Quantitative RT PCR and immunoblot analyses reveal acclimated A2 noradrenergic neuron substrate fuel transporter, glucokinase, phosphoAMPK, and dopamine-beta-hydroxylase responses to hypoglycemia. J Neurosci Res 89:1114-1124.
24. Koshy Cherian A, Briski KP. 2012. Estradiol regulates phosphoAMPK, glucokinase, sub-strate transporter, and dopamine-beta-hydroxylase adaptation to repeated insulin-induced hypoglycemia in female rat A2 noradrenergic neurons. J Neurosci Res 90:1347-1358.
25. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J. 1996. A cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93:5925-5930.
26. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
27. Marmigère F, Givalois L, Rage F, Arancibia S, Tapia-Arancibia L. 2003. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 13:646-655.
28. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ, Sherwin RS. 2004. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 53:1953-1958.
29. McCrimmon RJ, Shaw M, Fan X, Cheng H, Ding Y, Vella MC, Zhou L, McNay EC, Sherwin RS 2008. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes 57:444-450.
30. McDermott LJ, Jorgensen LE, Byers DJ. 1984. Estradiol and progesterone suppress feeding induced by 2-deoxy-D-glucose. Physiol Behav 32:731-736.
31. McEwen BS. 1999. The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 1999:1790-1797.
32. Mizuno Y, Oomura Y. 1984. Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res 307:109-116.
33. Morgan JI, Curran T. 1991. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14:421-451.
34. Nagatani S, Tsukamura H, Maeda K. 1994. Estrogen feedback needed at the paraventricular nucleus or A2 to suppress pulsatile luteinizing hormone release in fasting female rats. Endocrinology 135:870-875.
35. Nagatani S, Bucholtz DC, Murahashi K. 1996. Reduction of glucose availability suppresses pulsatile luteinizing hormone release in female and male rats. Endocrinology 137:1166-1170.
36. Nedungadi TP, Goleman WL, Paranjape SA, Kale AY, Briski KP. 2006. Effects of estradiol on glycemic and CNS neuronal activational responses to recurrent insulin-induced hypoglycemia in the ovariectomized female rat. Neuroendocrinology 84:235-243.
37. Nilsen J, Brinton RD. 2004. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disorders 3:297-313.
38. Oomura Y, Yoshimatsu H. 1984. Neural network of glucose monitoring system. J Auton Nerv Syst 10:359-372.
39. Pacak K. 2000. Stressor-specific activation of the hypothalamic-pituitary-adrenocortical axis. Physiol Res 49:S11-S117.
40. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. 1997. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508-1510.
41. Paranjape SA, Briski KP. 2005. Recurrent insulin-induced hypoglycemia causes site-specific patterns of habituation or amplification of CNS neuronal genomic activation. Neuroscience 130:957-970.
42. Park CJ, Zhao Z, Glidewell-Kenney C, Lazic M, Chambon P, Krust A, Weiss J, Clegg DJ, Dunaif A, Jameson JL, Levine JE. 2011. Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. J Clin Invest 121:604-612.
43. Reyes BAS, Estacio MA, l'Anson H, Tsukamura H, Maeda KI. 2001. Glucoprivation increases estrogen receptor α immunoreactivity in the brain catecholaminergic neurons in ovariectomized rats. Neurosci Lett 299:109-112.
44. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S. 2009. AMPK in the brain: its role in energy balance and neuroprotection. J Neurochem 109:17-23.
45. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. 2008. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 73:874-879.
46. Shimada K, Kitazato KT, Kinouchi T, Yagi K, Tada Y, Satomi J, Kageji T, Nagahiro S. 2011. Activation of estrogen receptor-α and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats. Hypertension 57:1161-1166.
47. Simerly RB, Chang C, Muramatsu M, Swanson LW. 1990. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294:76-95.
48. Simonian SX, Herbison AE. 1997. Differential expression of estrogen receptor and neuropeptide Y by brainstem A1 and A2 noradrenaline neurons. Neuroscience 76:517-529.
49. Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, Spangenberg J, Zornig C, Juhl HH, David KA. 2004. Tissue ischemia time affects gene and protein expression patterns within minutes. Biotechniques 36:1030-1037.
50. Swanson LW, Sawchenko PE, Berod A, Hartman BK, Helle KB, Van Orden DE. 1981. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus. J Comp Neurol 196:271-285.
51. Temel S, Lin W, Lakhlani S, Jennes L. 2002. Expression of estrogen receptor-alpha and cFos in norepinephrine and epinephrine neurons of young and mid-aged rats during the steroid-induced luteinizing hormone surge. Endocrinology 143:3974-3983.
52. Towler MC, Hardie DG. 2007. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100:328-341.
53. Wade GN, Schneider JE. 1992. Metabolic fuels and reproduction in female mammals. Neurosci Biobehav Rev 16:235-272.
54. Watts AG, Donovan CM. 2010. Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 31:32-43.
55. You L, Yin J. 2000. Patterns of regulation from mRNA and protein time series. Metab Eng 2:210-217.
56. Young CD, Lewis AS, Rudolph MC, Ruehle MD, Jackman MR. 2011. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS ONE 6:e23205. doi:10.1371/journal.pone.0023205.
57. Zhang QG, Raz L, Wang R, Han D, De Sevilla L, Yang F, Vadlamudi RK, Brann DW. 2009. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J Neurosci 29:13823-13836.